Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.21.
Market Cap
9T
Revenue
4.59T
Profits
199.05B
PE Ratio
45.21
Profit Margin
4.34%
Dividend Yield
0.39%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -2.71% | 1,001,190 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 616.62B | -1.14% | 3,055,001 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 434.48B | -1.60% | 1,846,705 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 385.84B | -1.58% | 1,719,442 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 304.75B | -1.34% | 2,339,980 | 65.77B |
| 6 | NVS | Novartis AG | 281.98B | -0.39% | 520,069 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 267.14B | -3.37% | 2,219,402 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 216.74B | 1.06% | 3,263,803 | 50.57B |
| 9 | AMGN | Amgen Inc. | 196.12B | -0.06% | 470,598 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 194.86B | -0.07% | 495,467 | 45.20B |
| 11 | ABT | Abbott Laboratories | 163.73B | -0.42% | 2,296,323 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 160.98B | -3.84% | 2,522,866 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 143.51B | -1.54% | 841,655 | 10.58B |
| 14 | DHR | Danaher Corporation | 140.95B | 1.61% | 1,355,654 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.33B | 0.08% | 12,420,476 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.12B | 1.48% | 2,597,738 | 405.62B |
| 17 | SYK | Stryker Corporation | 126.64B | 0.99% | 599,792 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 123.31B | -2.15% | 315,514 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 116.87B | -1.23% | 2,624,549 | 48.48B |
| 20 | MDT | Medtronic plc | 106.92B | 1.38% | 1,929,701 | 36.36B |
| 21 | SNY | Sanofi | 104.93B | -0.68% | 1,435,576 | 54.60B |
| 22 | GSK | GSK plc | 104.61B | 0.13% | 1,485,187 | 43.29B |
| 23 | MCK | McKesson Corporation | 93.54B | 0.77% | 189,613 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 91.04B | -0.28% | 215,408 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 89.43B | -1.43% | 932,233 | 76.39B |
| 26 | CI | The Cigna Group | 77.03B | -0.21% | 181,321 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.20B | -1.12% | 189,411 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.20B | -1.00% | 4,475,602 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.90B | 0.09% | 173,757 | 328.68B |
| 30 | ARGX | argenx SE | 56.98B | -3.44% | 225,752 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 55.09B | 0.62% | 577,018 | 250.74B |
| 32 | MDLN | Medline Inc. | 53.72B | 0.10% | 1,278,662 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.59B | 0.01% | 1,393,051 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 52.42B | -0.39% | 759,499 | 28.34B |
| 35 | HUM | Humana Inc. | 47.14B | -1.30% | 385,709 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.95B | 2.02% | 249,749 | 4.45B |
| 37 | HLN | Haleon plc | 42.54B | 0.72% | 2,450,470 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 41.87B | 0.74% | 319,038 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.90B | -1.81% | 532,709 | - |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.49B | -5.43% | 1,119,522 | 4.29B |
| 41 | NTRA | Natera, Inc. | 38.83B | -3.80% | 297,429 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.23B | -0.82% | 2,388,972 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 37.78B | 0.13% | 532,463 | 7.23B |
| 44 | WAT | Waters Corporation | 37.15B | 0.32% | 154,707 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.67B | -0.58% | 238,390 | 16.63B |
| 46 | CNC | Centene Corporation | 33.22B | -0.47% | 673,445 | 178.33B |
| 47 | ONC | BeOne Medicines AG | 33.21B | -1.37% | 102,620 | 5.74B |
| 48 | ALC | Alcon Inc. | 32.67B | 0.74% | 750,673 | 10.63B |
| 49 | RPRX | Royalty Pharma plc | 32.29B | -3.26% | 836,778 | 2.44B |
| 50 | ZTS | Zoetis Inc. | 32.22B | 2.36% | 2,373,720 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.88B | 0.21% | 830,866 | 3.32B |
| 52 | RMD | ResMed Inc. | 29.64B | -1.41% | 494,024 | 5.54B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 29.45B | 0.06% | 973,127 | 20.98B |
| 54 | BIIB | Biogen Inc. | 29.26B | -0.36% | 353,126 | 9.94B |
| 55 | ILMN | Illumina, Inc. | 28.98B | -1.14% | 325,892 | 4.39B |
| 56 | DXCM | DexCom, Inc. | 28.76B | 2.07% | 1,419,101 | 4.82B |
| 57 | MRNA | Moderna, Inc. | 26.88B | -11.51% | 5,265,682 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.06B | 0.11% | 28,954 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 26.03B | 0.77% | 310,182 | 20.34B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.71B | -2.91% | 2,462,466 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.03B | -0.95% | 163,472 | 3.22B |
| 62 | INSM | Insmed Incorporated | 24.62B | -3.94% | 1,322,764 | 819.56M |
| 63 | INCY | Incyte Corporation | 23.26B | -1.75% | 694,164 | 5.36B |
| 64 | DGX | Quest Diagnostics Incorporated | 23.13B | 0.43% | 177,221 | 11.28B |
| 65 | BNTX | BioNTech SE | 23.07B | -1.87% | 265,733 | 3.23B |
| 66 | UTHR | United Therapeutics Corporation | 23.04B | -1.74% | 85,152 | 3.17B |
| 67 | LH | Labcorp Holdings Inc. | 22.88B | 0.49% | 102,946 | 14.14B |
| 68 | STE | STERIS plc | 21.02B | -0.13% | 142,847 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 20.95B | -3.73% | 769,024 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.86B | -0.89% | 3,143,290 | 14.56B |
| 71 | GMAB | Genmab A/S | 18.12B | -3.36% | 2,854,141 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 17.69B | 2.49% | 564,970 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.68B | -2.59% | 404,286 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 17.44B | -2.08% | 201,344 | 21.46B |
| 75 | BBIO | BridgeBio Pharma, Inc. | 16.95B | -4.11% | 3,080,018 | 579.96M |
| 76 | ASND | Ascendis Pharma A/S | 16.71B | -2.31% | 170,685 | 998.25M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.30B | 0.05% | 73,133 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.13B | -2.44% | 285,954 | 4.44B |
| 79 | DVA | DaVita Inc. | 14.96B | 1.57% | 248,311 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.84B | -0.49% | 748,141 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.21B | -0.96% | 827,549 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.85B | -0.01% | 388,842 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.24B | 0.62% | 142,730 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 12.92B | -0.04% | 108,074 | 8.27B |
| 85 | SNN | Smith & Nephew plc | 12.77B | 0.82% | 923,097 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.75B | -0.11% | 255,143 | 4.10B |
| 87 | FMS | Fresenius Medical Care AG | 12.72B | 0.25% | 133,245 | 22.32B |
| 88 | RVTY | Revvity, Inc. | 12.61B | 0.08% | 188,627 | 2.90B |
| 89 | PEN | Penumbra, Inc. | 12.49B | -0.10% | 54,489 | 1.45B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.34B | 0.37% | 1,640,655 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.32B | -4.58% | 101,968 | 1.13B |
| 92 | MOH | Molina Healthcare, Inc. | 12.18B | 0.75% | 220,805 | 43.10B |
| 93 | ABVX | ABIVAX Société Anonyme | 12.11B | -0.65% | 437,355 | 5.67M |
| 94 | AXSM | Axsome Therapeutics, Inc. | 12.08B | -5.72% | 383,257 | 708.24M |
| 95 | SMMT | Summit Therapeutics Inc. | 11.75B | -2.20% | 1,240,713 | - |
| 96 | BAX | Baxter International Inc. | 11.68B | 0.71% | 1,081,907 | 11.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.45B | -1.25% | 447,518 | 3.24B |
| 98 | CYTK | Cytokinetics, Incorporated | 11.45B | -2.06% | 698,633 | 105.82M |
| 99 | CRL | Charles River Laboratories International, Inc. | 11.27B | 0.18% | 396,317 | 4.03B |
| 100 | PODD | Insulet Corporation | 11.12B | 1.42% | 209,994 | 2.90B |
| 101 | TECH | Bio-Techne Corporation | 11.10B | 0.08% | 1,067,701 | 1.21B |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.98B | -7.20% | 1,480,761 | 622.01M |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.87B | -5.58% | 1,621,975 | 3.58B |
| 104 | EHC | Encompass Health Corporation | 10.86B | -1.42% | 382,509 | 6.07B |
| 105 | GMED | Globus Medical, Inc. | 10.62B | 2.10% | 531,425 | 3.10B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.59B | -3.27% | 166,117 | 417.30M |
| 107 | TEM | Tempus AI, Inc. | 10.46B | -5.28% | 2,042,797 | 1.36B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.01B | 0.02% | 393,755 | - |
| 109 | NUVL | Nuvalent, Inc. | 9.83B | 0.04% | 1,310,506 | - |
| 110 | CORT | Corcept Therapeutics Incorporated | 9.78B | -2.31% | 385,636 | 769.10M |
| 111 | IONS | Ionis Pharmaceuticals, Inc. | 9.74B | -8.31% | 6,296,325 | 1.06B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.72B | -0.69% | 222,049 | 51.48M |
| 113 | ENSG | The Ensign Group, Inc. | 9.70B | -0.97% | 113,911 | 5.27B |
| 114 | HSIC | Henry Schein, Inc. | 9.67B | 1.28% | 258,483 | 13.38B |
| 115 | UHS | Universal Health Services, Inc. | 9.33B | -0.74% | 152,197 | 17.76B |
| 116 | BRKR | Bruker Corporation | 9.24B | 0.15% | 316,411 | 3.46B |
| 117 | OSCR | Oscar Health, Inc. | 9.23B | -1.79% | 1,623,984 | 13.30B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 9.04B | -3.08% | 593,142 | 1.51B |
| 119 | GKOS | Glaukos Corporation | 8.96B | -1.54% | 296,780 | 551.35M |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 8.87B | -4.45% | 153,796 | 7.46M |
| 121 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | 0.07% | 3,425,055 | 18.07M |
| 122 | ALKS | Alkermes plc | 8.72B | -2.73% | 488,739 | 1.56B |
| 123 | QGEN | Qiagen N.V. | 8.65B | -0.43% | 1,700,503 | 2.10B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -3.44% | 286,681 | 74.06M |
| 125 | SYRE | Spyre Therapeutics, Inc. | 8.54B | -0.37% | 380,758 | - |
| 126 | IBRX | ImmunityBio, Inc. | 8.51B | -8.34% | 8,150,100 | 140.98M |
| 127 | PCVX | Vaxcyte, Inc. | 8.35B | -3.29% | 259,149 | - |
| 128 | IMVT | Immunovant, Inc. | 8.20B | -2.85% | 528,180 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.14B | -2.79% | 582,283 | 700.35M |
| 130 | RGEN | Repligen Corporation | 8.10B | -0.22% | 174,303 | 763.34M |
| 131 | ATR | AptarGroup, Inc. | 8.08B | 1.77% | 73,074 | 3.87B |
| 132 | BIO | Bio-Rad Laboratories, Inc. | 7.98B | 0.29% | 49,851 | 2.59B |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.97B | -2.88% | 7,828,454 | 2.37B |
| 134 | HQY | HealthEquity, Inc. | 7.81B | -1.48% | 258,201 | 1.34B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.48B | -5.52% | 157,398 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.34B | -5.76% | 219,228 | 569.61M |
| 137 | AVTR | Avantor, Inc. | 7.16B | -0.19% | 2,109,102 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 7.09B | -4.51% | 353,699 | 827.11M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.94B | 0.51% | 468,660 | 1.55B |
| 140 | LQDA | Liquidia Corporation | 6.92B | -4.51% | 604,466 | 288.07M |
| 141 | HNGE | Hinge Health, Inc. | 6.83B | -1.86% | 433,551 | 646.34M |
| 142 | PACS | PACS Group, Inc. | 6.73B | -3.01% | 276,782 | 5.43B |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.71B | -3.30% | 216,023 | - |
| 144 | COGT | Cogent Biosciences, Inc. | 6.66B | -3.88% | 1,051,440 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.60B | -3.79% | 750,397 | 7.50M |
| 146 | CHE | Chemed Corporation | 6.46B | -0.43% | 31,843 | 2.54B |
| 147 | CGON | CG Oncology, Inc. | 6.37B | -1.54% | 385,759 | 5.07M |
| 148 | GRFS | Grifols, S.A. | 6.21B | -1.58% | 362,436 | 8.58B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.19B | -3.08% | 57,336 | 274.48M |
| 150 | DFTX | Definium Therapeutics, Inc. | 6.09B | -5.26% | 1,110,562 | - |
| 151 | TFX | Teleflex Incorporated | 6.01B | 1.29% | 141,325 | 2.13B |
| 152 | BLLN | BillionToOne, Inc. | 5.81B | -1.21% | 412,771 | 354.54M |
| 153 | ERAS | Erasca, Inc. | 5.79B | -2.87% | 1,357,340 | - |
| 154 | BLTE | Belite Bio, Inc | 5.78B | -4.19% | 75,753 | - |
| 155 | BLCO | Bausch + Lomb Corporation | 5.73B | -3.92% | 84,085 | 5.21B |
| 156 | TWST | Twist Bioscience Corporation | 5.65B | -3.14% | 641,682 | 409.48M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.42B | -0.12% | 746,060 | 3.05B |
| 158 | TXG | 10x Genomics, Inc. | 5.42B | -1.00% | 1,299,889 | 638.78M |
| 159 | STVN | Stevanato Group S.p.A. | 5.37B | -0.35% | 192,163 | 1.39B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 5.32B | -2.72% | 412,456 | 1.34M |
| 161 | CELC | Celcuity Inc. | 5.32B | -3.98% | 350,782 | - |
| 162 | SHC | Sotera Health Company | 5.25B | 0.11% | 678,391 | 1.19B |
| 163 | TVTX | Travere Therapeutics, Inc. | 5.23B | -3.80% | 606,254 | 536.20M |
| 164 | ORKA | Oruka Therapeutics, Inc. | 5.22B | -1.87% | 231,101 | - |
| 165 | LEGN | Legend Biotech Corporation | 5.21B | -1.72% | 417,169 | 1.14B |
| 166 | RDNT | RadNet, Inc. | 5.16B | -0.56% | 112,973 | 2.14B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.15B | -5.17% | 1,200,605 | 4.10M |
| 168 | MANE | Veradermics, Incorporated | 4.96B | -5.03% | 142,221 | - |
| 169 | CAI | Caris Life Sciences, Inc. | 4.93B | -2.35% | 904,116 | 907.29M |
| 170 | INDV | Indivior Pharmaceuticals, Inc. | 4.93B | -2.18% | 477,268 | 1.29B |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.90B | -2.68% | 179,974 | 754.05M |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -8.17% | 423,246 | - |
| 173 | VCYT | Veracyte, Inc. | 4.58B | -3.25% | 254,862 | 541.74M |
| 174 | VKTX | Viking Therapeutics, Inc. | 4.51B | -5.54% | 1,241,671 | - |
| 175 | LIVN | LivaNova PLC | 4.50B | -0.70% | 110,381 | 1.43B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | -0.72% | 317,809 | 1.10B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.41B | -0.20% | 1,463,569 | 56.99M |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.34B | 1.83% | 227,847 | 1.54B |
| 179 | WAY | Waystar Holding Corp. | 4.33B | -2.63% | 552,447 | 1.16B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.31B | -4.72% | 1,557,541 | 10.68M |
| 181 | NVST | Envista Holdings Corporation | 4.22B | 0.66% | 1,545,360 | 2.81B |
| 182 | MMED | MiniMed Group, Inc. | 4.14B | -2.13% | 329,099 | 3.10B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.13B | -1.34% | 1,011,053 | 1.49B |
| 184 | ALHC | Alignment Healthcare, Inc. | 4.08B | -6.13% | 1,535,678 | 4.26B |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 4.08B | -2.90% | 164,308 | 22.57M |
| 186 | DNLI | Denali Therapeutics Inc. | 4.05B | -6.25% | 627,720 | - |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 4.01B | -0.32% | 260,552 | 2.23B |
| 188 | DOCS | Doximity, Inc. | 3.97B | -1.36% | 410,405 | 644.86M |
| 189 | ICUI | ICU Medical, Inc. | 3.86B | -1.25% | 60,780 | 2.16B |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 500,308 | 596.96M |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.83B | -5.09% | 102,682 | 803.79M |
| 192 | DYN | Dyne Therapeutics, Inc. | 3.81B | -5.03% | 698,138 | - |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.80B | -1.64% | 323,175 | - |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.80B | -1.90% | 171,164 | 787.85M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.78B | -3.65% | 381,766 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.60B | -4.34% | 238,728 | 236.00M |
| 197 | ALMS | Alumis Inc. | 3.59B | -7.06% | 397,587 | 8.40M |
| 198 | WRBY | Warby Parker Inc. | 3.59B | -0.24% | 632,512 | 890.57M |
| 199 | OGN | Organon & Co. | 3.55B | 0.11% | 2,291,776 | 6.16B |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.51B | -3.68% | 265,358 | - |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | -1.56% | 244,615 | 225.27M |
| 202 | HAE | Haemonetics Corporation | 3.47B | 1.75% | 143,318 | 1.33B |
| 203 | PRVA | Privia Health Group, Inc. | 3.46B | -1.24% | 288,570 | 2.25B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.45B | -4.07% | 611,251 | 415.62M |
| 205 | OPCH | Option Care Health, Inc. | 3.45B | 1.43% | 519,882 | 5.67B |
| 206 | BKD | Brookdale Senior Living Inc. | 3.35B | -8.05% | 7,352,305 | 3.00B |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 3.34B | -4.31% | 707,821 | 295.41M |
| 208 | BEAM | Beam Therapeutics Inc. | 3.28B | -7.90% | 1,755,627 | 164.01M |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.27B | -3.67% | 594,807 | 670.00M |
| 210 | NHC | National HealthCare Corporation | 3.26B | -2.42% | 42,334 | 1.53B |
| 211 | ITGR | Integer Holdings Corporation | 3.16B | 1.20% | 50,914 | 1.86B |
| 212 | GRAL | GRAIL, Inc. | 3.05B | -6.12% | 190,274 | 156.12M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.01B | -1.62% | 180,468 | 865.00K |
| 214 | QURE | uniQure N.V. | 2.92B | -4.36% | 524,162 | 18.09M |
| 215 | MBX | MBX Biosciences, Inc. | 2.91B | -6.85% | 447,385 | - |
| 216 | IRON | Disc Medicine, Inc. | 2.90B | -3.69% | 144,577 | - |
| 217 | VERA | Vera Therapeutics, Inc. | 2.90B | -4.83% | 1,052,991 | - |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.90B | -3.62% | 155,172 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | -0.06% | 732,501 | 3.37B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.79B | -1.35% | 269,228 | 776.83M |
| 221 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.65B | -2.80% | 1,377,393 | 885.72M |
| 222 | KLRA | Kailera Therapeutics, Inc. | 2.63B | -3.45% | 191,296 | - |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | -0.80% | 116,022 | 1.46B |
| 224 | IMNM | Immunome, Inc. | 2.57B | -6.25% | 415,149 | 4.02M |
| 225 | SLS | SELLAS Life Sciences Group, Inc. | 2.56B | -3.77% | 4,077,696 | - |
| 226 | ESTA | Establishment Labs Holdings Inc. | 2.54B | -2.67% | 102,749 | 229.58M |
| 227 | TARS | Tarsus Pharmaceuticals, Inc. | 2.53B | -8.22% | 802,567 | 535.08M |
| 228 | KOD | Kodiak Sciences Inc. | 2.53B | 1.10% | 471,859 | - |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -3.26% | 460,174 | - |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -3.00% | 280,994 | - |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.46B | 3.11% | 1,401,419 | 3.68B |
| 232 | TMDX | TransMedics Group, Inc. | 2.45B | -1.65% | 182,776 | 635.89M |
| 233 | AGIO | Agios Pharmaceuticals, Inc. | 2.45B | -3.88% | 600,152 | 66.05M |
| 234 | PHVS | Pharvaris N.V. | 2.42B | -3.56% | 300,928 | - |
| 235 | PGNY | Progyny, Inc. | 2.39B | -1.64% | 224,207 | 1.29B |
| 236 | VCEL | Vericel Corporation | 2.39B | -3.12% | 168,484 | 292.09M |
| 237 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -6.84% | 633,558 | 36.77M |
| 238 | BHVN | Biohaven Ltd. | 2.38B | -5.72% | 702,372 | - |
| 239 | CLOV | Clover Health Investments, Corp. | 2.36B | -4.38% | 2,719,349 | 2.21B |
| 240 | LMAT | LeMaitre Vascular, Inc. | 2.35B | 0.40% | 113,317 | 256.28M |
| 241 | NKTR | Nektar Therapeutics | 2.33B | -5.33% | 382,098 | 55.63M |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.33B | 1.32% | 112,371 | 1.09B |
| 243 | ZLAB | Zai Lab Limited | 2.31B | 3.05% | 329,719 | 453.28M |
| 244 | HTFL | HeartFlow, Inc. | 2.30B | -3.82% | 276,547 | 191.42M |
| 245 | ASTH | Astrana Health, Inc. | 2.28B | -1.62% | 118,116 | 3.53B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.22B | -3.65% | 673,016 | 52.04M |
| 247 | AXGN | Axogen, Inc. | 2.18B | -6.18% | 1,131,710 | 238.11M |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.16B | -3.12% | 674,763 | 70.92M |
| 249 | ADMA | ADMA Biologics, Inc. | 2.14B | -0.54% | 725,411 | 509.86M |
| 250 | SGRY | Surgery Partners, Inc. | 2.13B | -1.97% | 333,128 | 3.34B |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | -4.11% | 359,723 | 899.11M |
| 252 | MD | Pediatrix Medical Group, Inc. | 2.11B | -2.21% | 123,662 | 1.93B |
| 253 | AVAH | Aveanna Healthcare Holdings Inc. | 2.10B | -1.93% | 691,500 | 2.52B |
| 254 | KARD | Kardigan, Inc. | 2.08B | -4.74% | 119,501 | - |
| 255 | ABCL | AbCellera Biologics Inc. | 2.08B | -6.79% | 3,204,775 | 79.21M |
| 256 | NEOG | Neogen Corporation | 2.07B | -2.31% | 581,002 | 870.56M |
| 257 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | -6.32% | 892,805 | 217.17M |
| 258 | NUVB | Nuvation Bio Inc. | 2.05B | -3.60% | 3,049,889 | 143.05M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -5.33% | 86,685 | - |
| 260 | NTLA | Intellia Therapeutics, Inc. | 2.03B | -5.76% | 3,865,796 | 66.09M |
| 261 | OMCL | Omnicell, Inc. | 2.03B | -2.30% | 155,000 | 1.23B |
| 262 | MESO | Mesoblast Limited | 2.02B | 4.18% | 192,917 | 65.38M |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -5.73% | 525,350 | 298.30M |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -7.50% | 1,556,012 | 2.18B |
| 265 | BFLY | Butterfly Network, Inc. | 2.00B | -4.86% | 2,838,688 | 102.92M |
| 266 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | -5.33% | 1,421,930 | 7.47M |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.98B | -1.18% | 68,649 | 1.20B |
| 268 | ADUS | Addus HomeCare Corporation | 1.98B | -1.33% | 97,304 | 1.45B |
| 269 | NBTX | Nanobiotix S.A. | 1.98B | 2.39% | 90,969 | 38.27M |
| 270 | HCM | HUTCHMED (China) Limited | 1.96B | 1.00% | 12,181 | 548.51M |
| 271 | SION | Sionna Therapeutics, Inc. | 1.96B | -3.60% | 127,133 | - |
| 272 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.95B | -4.68% | 434,114 | -665.00K |
| 273 | WGS | GeneDx Holdings Corp. | 1.94B | -5.68% | 195,512 | 442.68M |
| 274 | RAPP | Rapport Therapeutics, Inc. | 1.94B | -3.39% | 231,533 | 20.00M |
| 275 | GLUE | Monte Rosa Therapeutics, Inc. | 1.93B | -6.61% | 991,588 | 42.95M |
| 276 | ANAB | AnaptysBio, Inc. | 1.93B | -2.07% | 142,580 | 232.39M |
| 277 | STOK | Stoke Therapeutics, Inc. | 1.93B | -5.70% | 217,906 | 32.08M |
| 278 | URGN | UroGen Pharma Ltd. | 1.92B | -1.86% | 432,200 | 140.49M |
| 279 | IOVA | Iovance Biotherapeutics, Inc. | 1.92B | -1.60% | 6,253,951 | 285.61M |
| 280 | NVCR | NovoCure Limited | 1.90B | -5.00% | 413,650 | 674.41M |
| 281 | BCAX | Bicara Therapeutics Inc. | 1.88B | -3.37% | 222,036 | - |
| 282 | TYRA | Tyra Biosciences, Inc. | 1.88B | -4.18% | 472,372 | - |
| 283 | ATAI | AtaiBeckley Inc. | 1.87B | -4.50% | 4,268,708 | 3.49M |
| 284 | UFPT | UFP Technologies, Inc. | 1.87B | -3.30% | 134,158 | 608.85M |
| 285 | ALMR | Alamar Biosciences, Inc. | 1.87B | 1.74% | 50,133 | 87.16M |
| 286 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | -6.52% | 12,802,232 | 66.41M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.86B | -1.63% | 310,950 | 367.34M |
| 288 | CMPS | COMPASS Pathways plc | 1.86B | 1.54% | 2,268,831 | - |
| 289 | PGEN | Precigen, Inc. | 1.86B | -5.70% | 1,726,375 | 31.60M |
| 290 | AGL | agilon health, inc. | 1.85B | -4.18% | 73,258 | 5.82B |
| 291 | ZYME | Zymeworks Inc. | 1.84B | -4.95% | 224,567 | 81.26M |
| 292 | GENB | Generate Biomedicines, Inc. | 1.84B | -8.65% | 479,690 | 30.30M |
| 293 | PLSE | Pulse Biosciences, Inc. | 1.84B | -2.61% | 112,927 | 751.00K |
| 294 | NEO | NeoGenomics, Inc. | 1.83B | -4.82% | 468,379 | 745.97M |
| 295 | DMRA | Damora Therapeutics, Inc. | 1.82B | -3.75% | 124,901 | - |
| 296 | GHRS | GH Research PLC | 1.81B | -3.24% | 67,351 | - |
| 297 | ABSI | Absci Corporation | 1.79B | -8.02% | 1,956,849 | 1.84M |
| 298 | BHC | Bausch Health Companies Inc. | 1.77B | -2.37% | 824,984 | 10.53B |
| 299 | ZBIO | Zenas BioPharma, Inc. | 1.75B | -5.71% | 329,334 | 10.00M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.75B | -1.47% | 105,755 | 923.71M |
| 301 | MLTX | MoonLake Immunotherapeutics | 1.72B | 4.52% | 956,415 | - |
| 302 | ATRC | AtriCure, Inc. | 1.71B | -2.42% | 145,469 | 552.16M |
| 303 | AAPG | Ascentage Pharma Group International | 1.71B | 1.80% | 2,064 | 82.08M |
| 304 | MPLT | MapLight Therapeutics, Inc. | 1.70B | -5.60% | 723,255 | - |
| 305 | FTRE | Fortrea Holdings Inc. | 1.66B | -0.76% | 314,658 | 2.71B |
| 306 | TDOC | Teladoc Health, Inc. | 1.65B | -0.60% | 931,313 | 2.51B |
| 307 | COAG | Hemab Therapeutics Holdings, Inc. | 1.65B | -4.99% | 62,141 | - |
| 308 | VIR | Vir Biotechnology, Inc. | 1.65B | -5.42% | 936,475 | 65.50M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.65B | -8.24% | 351,921 | 20.00M |
| 310 | IMCR | Immunocore Holdings plc | 1.64B | -2.46% | 124,416 | 412.81M |
| 311 | TRLV | Trulieve Cannabis Corp. | 1.64B | -3.62% | 798,483 | 1.17B |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.63B | -1.33% | 158,323 | 1.85B |
| 313 | INVA | Innoviva, Inc. | 1.63B | -0.41% | 245,238 | 420.69M |
| 314 | SEPN | Septerna, Inc. | 1.62B | -5.05% | 131,759 | 72.26M |
| 315 | HROW | Harrow, Inc. | 1.58B | -1.40% | 247,808 | 268.68M |
| 316 | AVBP | ArriVent BioPharma, Inc. | 1.55B | -1.14% | 133,135 | - |
| 317 | AKTS | Aktis Oncology, Inc. | 1.54B | -1.90% | 251,879 | 8.28M |
| 318 | INNV | InnovAge Holding Corp. | 1.54B | -4.54% | 54,790 | 949.17M |
| 319 | SVRA | Savara Inc. | 1.53B | -4.21% | 569,789 | - |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.52B | -1.17% | 619,672 | 204.73M |
| 321 | NVAX | Novavax, Inc. | 1.51B | -2.55% | 3,309,213 | 596.34M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | -3.84% | 96,137 | 83.72M |
| 323 | CDNA | CareDx, Inc. | 1.47B | -1.96% | 161,166 | 412.82M |
| 324 | ENOV | Enovis Corporation | 1.47B | 1.39% | 169,872 | 2.28B |
| 325 | PSNL | Personalis, Inc. | 1.47B | -4.51% | 1,757,276 | 64.52M |
| 326 | INSP | Inspire Medical Systems, Inc. | 1.46B | -1.80% | 224,801 | 915.25M |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.45B | -1.10% | 468,585 | 787.08M |
| 328 | IART | Integra LifeSciences Holdings Corporation | 1.44B | 0.71% | 295,621 | 1.64B |
| 329 | XERS | Xeris Biopharma Holdings, Inc. | 1.44B | -3.48% | 749,571 | 314.85M |
| 330 | ARDT | Ardent Health, Inc. | 1.42B | -1.59% | 93,884 | 6.43B |
| 331 | PRGO | Perrigo Company plc | 1.42B | -1.25% | 915,639 | 4.18B |
| 332 | PNTG | The Pennant Group, Inc. | 1.40B | -0.54% | 125,103 | 1.02B |
| 333 | STAA | STAAR Surgical Company | 1.37B | -1.75% | 123,095 | 290.38M |
| 334 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -10.28% | 179,618 | 1.30M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.36B | -1.04% | 153,931 | 101.66M |
| 336 | OMDA | Omada Health, Inc. | 1.36B | -2.76% | 263,773 | 283.30M |
| 337 | AHCO | AdaptHealth Corp. | 1.34B | -0.98% | 209,074 | 3.29B |
| 338 | PAHC | Phibro Animal Health Corporation | 1.33B | 1.14% | 70,285 | 1.50B |
| 339 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -3.15% | 493,907 | - |
| 340 | IMTX | Immatics N.V. | 1.30B | -4.32% | 133,763 | 43.00M |
| 341 | ARDX | Ardelyx, Inc. | 1.30B | -2.23% | 956,668 | 427.68M |
| 342 | AHG | Akso Health Group | 1.29B | 1.34% | 661 | 14.84M |
| 343 | MNKD | MannKind Corporation | 1.29B | 0.72% | 2,013,626 | 360.78M |
| 344 | NUTX | Nutex Health Inc. | 1.26B | 0.16% | 52,869 | 879.95M |
| 345 | MGTX | MeiraGTx Holdings plc | 1.25B | -3.30% | 298,108 | 79.76M |
| 346 | QDEL | QuidelOrtho Corporation | 1.25B | 4.87% | 315,242 | 2.66B |
| 347 | IRMD | IRADIMED CORPORATION | 1.25B | -0.52% | 41,079 | 86.28M |
| 348 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -4.49% | 624,343 | 11.13M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.24B | -7.07% | 665,197 | - |
| 350 | TRAX | First Tracks Biotherapeutics, Inc. | 1.24B | 9.54% | 1,128,812 | - |
| 351 | AVLN | Avalyn Pharma Inc. | 1.23B | -3.70% | 230,880 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.23B | 0.79% | 200,312 | 3.42B |
| 353 | SDGR | Schrödinger, Inc. | 1.22B | -2.98% | 487,941 | 254.91M |
| 354 | EYPT | EyePoint, Inc. | 1.20B | -3.37% | 696,266 | 7.61M |
| 355 | GMRS | GMR Solutions Inc. | 1.18B | -3.88% | 144,838 | 5.83B |
| 356 | ALVO | Alvotech | 1.17B | -1.05% | 131,178 | 562.04M |
| 357 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | 4.05% | 350,917 | 322.02M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | -0.02% | 80,221 | 715.90M |
| 359 | AZTA | Azenta, Inc. | 1.17B | -0.35% | 161,886 | 596.48M |
| 360 | AORT | Artivion, Inc. | 1.16B | -0.87% | 108,126 | 458.69M |
| 361 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | -0.61% | 76,285 | 796.33M |
| 362 | CNMD | CONMED Corporation | 1.15B | 4.12% | 566,677 | 1.37B |
| 363 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | -1.81% | 181,842 | 1.03B |
| 364 | XNCR | Xencor, Inc. | 1.14B | -4.34% | 178,368 | 97.36M |
| 365 | WVE | Wave Life Sciences Ltd. | 1.14B | -5.86% | 1,225,251 | 71.80M |
| 366 | SANA | Sana Biotechnology, Inc. | 1.12B | -4.71% | 1,272,339 | - |
| 367 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -4.78% | 427,765 | - |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.11B | -0.33% | 58,659 | 787.69M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -2.50% | 246,845 | - |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 1.10B | -3.02% | 487,095 | - |
| 371 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -2.29% | 23,079 | - |
| 372 | BIOA | BioAge Labs, Inc. | 1.06B | -3.98% | 396,717 | 10.32M |
| 373 | CERT | Certara, Inc. | 1.05B | -0.66% | 817,182 | 419.75M |
| 374 | FBRX | Forte Biosciences, Inc. | 1.05B | 16.95% | 1,991,083 | - |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.04B | -1.17% | 324,246 | 1.03B |
| 376 | CRON | Cronos Group Inc. | 1.04B | -0.90% | 148,106 | 159.54M |
| 377 | OPK | OPKO Health, Inc. | 1.02B | -2.52% | 1,289,019 | 581.12M |
| 378 | SLDB | Solid Biosciences Inc. | 1.02B | -6.73% | 708,902 | - |
| 379 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | -4.64% | 308,839 | - |
| 380 | EVO | Evotec SE | 1.01B | -2.11% | 16,359 | 859.03M |
| 381 | PHAR | Pharming Group N.V. | 1.01B | -7.41% | 12,170 | 369.49M |
| 382 | VOR | Vor Biopharma Inc. | 1.01B | -5.72% | 1,406,850 | - |
| 383 | IVA | Inventiva S.A. | 1.01B | -5.30% | 343,394 | 7.94M |
| 384 | GDRX | GoodRx Holdings, Inc. | 1.00B | 0.68% | 264,878 | 787.89M |
| 385 | KURA | Kura Oncology, Inc. | 1.00B | -6.62% | 600,711 | 71.64M |
| 386 | PCRX | Pacira BioSciences, Inc. | 995.90M | -0.75% | 127,099 | 734.86M |
| 387 | BVS | Bioventus Inc. | 994.06M | -2.62% | 262,745 | 576.30M |
| 388 | ETON | Eton Pharmaceuticals, Inc. | 992.86M | -2.90% | 111,848 | 86.93M |
| 389 | JANX | Janux Therapeutics, Inc. | 987.34M | -3.34% | 292,525 | 13.73M |
| 390 | AVTX | Avalo Therapeutics, Inc. | 987.18M | -5.86% | 364,032 | 59.00K |
| 391 | PHAT | Phathom Pharmaceuticals, Inc. | 980.17M | 1.48% | 1,427,127 | 204.89M |
| 392 | INMD | InMode Ltd. | 970.34M | 2.03% | 427,343 | 374.64M |
| 393 | DBVT | DBV Technologies S.A. | 964.06M | 0.16% | 100,233 | 5.74M |
| 394 | GLAS | Glass House Brands Inc. | 963.05M | -2.50% | 102,100 | 177.68M |
| 395 | LXRX | Lexicon Pharmaceuticals, Inc. | 959.46M | -4.00% | 959,888 | 69.64M |
| 396 | GERN | Geron Corporation | 955.87M | -4.49% | 5,374,350 | 196.12M |
| 397 | DSGN | Design Therapeutics, Inc. | 932.17M | -3.21% | 318,716 | - |
| 398 | AVR | Anteris Technologies Global Corp. | 931.56M | 0.84% | 282,786 | 1.85M |
| 399 | ABUS | Arbutus Biopharma Corporation | 930.40M | -8.37% | 1,455,355 | 191.45M |
| 400 | ANRO | Alto Neuroscience, Inc. | 929.64M | -4.16% | 213,253 | - |
| 401 | LBRX | LB Pharmaceuticals Inc | 924.82M | -4.42% | 81,783 | - |
| 402 | ANNX | Annexon, Inc. | 916.70M | -5.81% | 1,147,539 | - |
| 403 | REPL | Replimune Group, Inc. | 911.64M | -2.25% | 1,113,944 | - |
| 404 | FTH | Faeth Therapeutics, Inc. | 903.29M | 7.68% | 99,106 | - |
| 405 | TENX | Tenax Therapeutics, Inc. | 890.02M | -4.91% | 557,407 | - |
| 406 | TBPH | Theravance Biopharma, Inc. | 881.34M | 0.15% | 324,469 | 109.78M |
| 407 | TALK | Talkspace, Inc. | 873.58M | -0.10% | 1,031,177 | 238.37M |
| 408 | AMPH | Amphastar Pharmaceuticals, Inc. | 839.53M | 0.11% | 83,609 | 720.53M |
| 409 | ESPR | Esperion Therapeutics, Inc. | 820.75M | -0.16% | 13,373,090 | 418.24M |
| 410 | HSTM | HealthStream, Inc. | 817.73M | -0.11% | 53,737 | 311.78M |
| 411 | OCS | Oculis Holding AG | 812.22M | -1.82% | 101,744 | 1.40M |
| 412 | CTMX | CytomX Therapeutics, Inc. | 808.77M | -6.07% | 1,544,540 | 35.54M |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 793.74M | -1.97% | 185,409 | 299.77M |
| 414 | CLYM | Climb Bio, Inc. | 791.91M | 0.07% | 433,662 | - |
| 415 | SLBT | SL Science Holding Limited | 787.92M | 6.91% | 97,122 | - |
| 416 | NGNE | Neurogene Inc. | 782.53M | -8.33% | 140,211 | 925.00K |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 780.32M | -5.31% | 976,608 | 122.29M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 778.63M | -2.36% | 644,436 | 8.37M |
| 419 | SPRY | ARS Pharmaceuticals, Inc. | 776.55M | -0.76% | 641,804 | 98.99M |
| 420 | IMMX | Immix Biopharma, Inc. | 774.55M | -1.89% | 719,282 | - |
| 421 | SIBN | SI-BONE, Inc. | 769.46M | -0.40% | 201,892 | 206.22M |
| 422 | DRUG | Bright Minds Biosciences Inc. | 762.82M | -7.25% | 125,260 | - |
| 423 | ODTX | Odyssey Therapeutics, Inc. | 756.95M | -6.06% | 99,123 | 1.06M |
| 424 | AURA | Aura Biosciences, Inc. | 748.93M | -3.00% | 144,113 | - |
| 425 | CBLL | CeriBell, Inc. | 743.30M | -0.25% | 85,464 | 95.07M |
| 426 | SSII | SS Innovations International, Inc. | 738.13M | -2.43% | 45,650 | 48.47M |
| 427 | OMER | Omeros Corporation | 737.50M | -0.78% | 505,488 | 9.89M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 736.64M | -4.18% | 1,375,644 | 361.51M |
| 429 | BBNX | Beta Bionics, Inc. | 733.49M | 0.18% | 191,144 | 110.24M |
| 430 | GYRE | Gyre Therapeutics, Inc. | 731.37M | -4.37% | 37,872 | 117.05M |
| 431 | RGNX | REGENXBIO Inc. | 715.51M | -11.57% | 2,402,879 | 87.82M |
| 432 | CSTL | Castle Biosciences, Inc. | 713.97M | -4.15% | 67,213 | 339.92M |
| 433 | SGP | SpyGlass Pharma, Inc. | 709.79M | 5.78% | 80,596 | - |
| 434 | MNPR | Monopar Therapeutics Inc. | 694.23M | -0.83% | 102,166 | - |
| 435 | CADL | Candel Therapeutics, Inc. | 690.94M | -4.65% | 590,977 | - |
| 436 | ALLO | Allogene Therapeutics, Inc. | 683.41M | -5.71% | 4,249,427 | 22.00K |
| 437 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 674.50M | -7.37% | 184,338 | - |
| 438 | PRME | Prime Medicine, Inc. | 673.70M | -11.82% | 3,955,713 | 4.03M |
| 439 | RLMD | Relmada Therapeutics, Inc. | 667.63M | -2.23% | 601,485 | - |
| 440 | TCMD | Tactile Systems Technology, Inc. | 667.21M | -3.59% | 158,440 | 343.52M |
| 441 | PHR | Phreesia, Inc. | 660.15M | -1.29% | 222,629 | 495.59M |
| 442 | CRMD | CorMedix Inc. | 657.43M | -3.34% | 469,984 | 400.05M |
| 443 | TECX | Tectonic Therapeutic, Inc. | 653.82M | -1.76% | 43,958 | - |
| 444 | EVH | Evolent Health, Inc. | 650.14M | 2.66% | 712,010 | 1.89B |
| 445 | AGMB | AgomAb Therapeutics NV | 644.16M | 0.38% | 21,500 | - |
| 446 | FDMT | 4D Molecular Therapeutics, Inc. | 627.32M | -6.90% | 385,115 | 88.24M |
| 447 | CERS | Cerus Corporation | 625.15M | -0.95% | 771,086 | 216.56M |
| 448 | ACHV | Achieve Life Sciences, Inc. | 618.01M | -5.94% | 1,181,334 | - |
| 449 | MDXG | MiMedx Group, Inc. | 612.91M | -0.60% | 243,919 | 389.42M |
| 450 | BWAY | BrainsWay Ltd. | 606.60M | 0.03% | 19,819 | 56.22M |
| 451 | CTKB | Cytek Biosciences, Inc. | 590.18M | -0.44% | 219,918 | 204.17M |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 588.57M | -7.40% | 722,019 | 151.40M |
| 453 | ALT | Altimmune, Inc. | 586.34M | -3.37% | 1,729,822 | 36.00K |
| 454 | FLGT | Fulgent Genetics, Inc. | 579.94M | -2.20% | 71,923 | 320.35M |
| 455 | NVCT | Nuvectis Pharma, Inc. | 577.23M | -3.58% | 94,748 | - |
| 456 | NPCE | NeuroPace, Inc. | 571.07M | -1.30% | 49,585 | 99.53M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 564.35M | -2.30% | 111,110 | - |
| 458 | TOI | The Oncology Institute, Inc. | 557.90M | -4.62% | 688,231 | 545.76M |
| 459 | MYGN | Myriad Genetics, Inc. | 554.41M | -3.77% | 398,461 | 829.00M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 553.84M | -8.82% | 129,068 | - |
| 461 | CBIO | Crescent Biopharma, Inc. | 552.10M | -0.87% | 167,107 | 11.88M |
| 462 | XOMA | XOMA Royalty Corporation | 551.12M | -1.91% | 68,397 | 48.56M |
| 463 | WEAV | Weave Communications, Inc. | 548.21M | 1.77% | 296,443 | 248.72M |
| 464 | ARVN | Arvinas, Inc. | 536.49M | -2.63% | 197,596 | 89.40M |
| 465 | ANGO | AngioDynamics, Inc. | 534.78M | -0.70% | 85,432 | 313.73M |
| 466 | CTEV | Claritev Corporation | 534.62M | -4.68% | 35,309 | 978.76M |
| 467 | ASMB | Assembly Biosciences, Inc. | 527.54M | -4.49% | 77,549 | 71.10M |
| 468 | TLRY | Tilray Brands, Inc. | 525.44M | 0.34% | 1,931,604 | 858.28M |
| 469 | PROK | ProKidney Corp. | 521.05M | -4.17% | 417,693 | 889.00K |
| 470 | KYTX | Kyverna Therapeutics, Inc. | 521.01M | -12.64% | 1,252,554 | - |
| 471 | RZLT | Rezolute, Inc. | 520.24M | -2.92% | 662,736 | - |
| 472 | KIDS | OrthoPediatrics Corp. | 515.75M | -0.74% | 17,747 | 243.30M |
| 473 | CLPT | ClearPoint Neuro, Inc. | 514.32M | -4.08% | 182,384 | 40.61M |
| 474 | AQST | Aquestive Therapeutics, Inc. | 506.82M | -4.72% | 1,574,094 | 50.27M |
| 475 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 476 | VALN | Valneva SE | 495.80M | -3.12% | 11,431 | 180.25M |
| 477 | STTK | Shattuck Labs, Inc. | 492.67M | -8.61% | 719,795 | 1.00M |
| 478 | OCGN | Ocugen, Inc. | 489.16M | -1.70% | 1,684,904 | 4.47M |
| 479 | CYH | Community Health Systems, Inc. | 487.63M | -2.70% | 327,840 | 12.29B |
| 480 | ZURA | Zura Bio Limited | 487.34M | -6.90% | 491,301 | - |
| 481 | NRC | NRC Health | 482.29M | -1.43% | 19,234 | 138.64M |
| 482 | CABA | Cabaletta Bio, Inc. | 478.57M | -5.78% | 4,377,521 | - |
| 483 | STRO | Sutro Biopharma, Inc. | 478.06M | -3.80% | 107,901 | 99.61M |
| 484 | PACB | Pacific Biosciences of California, Inc. | 476.77M | -4.66% | 3,397,598 | 160.03M |
| 485 | PRTA | Prothena Corporation plc | 474.58M | -5.96% | 244,674 | 57.94M |
| 486 | SOPH | SOPHiA GENETICS SA | 472.33M | -3.26% | 173,292 | 81.18M |
| 487 | VMD | Viemed Healthcare, Inc. | 467.90M | -0.45% | 108,698 | 286.57M |
| 488 | NNNN | Anbio Biotechnology | 466.56M | -4.66% | 9,510 | 8.65M |
| 489 | EDIT | Editas Medicine, Inc. | 466.52M | -7.88% | 2,034,595 | 38.69M |
| 490 | VREX | Varex Imaging Corporation | 466.14M | 2.69% | 109,917 | 857.50M |
| 491 | OVID | Ovid Therapeutics Inc. | 464.73M | -4.23% | 706,405 | 7.12M |
| 492 | OFIX | Orthofix Medical Inc. | 464.44M | 0.09% | 54,589 | 825.37M |
| 493 | EVMN | Evommune, Inc. | 463.74M | -4.70% | 282,341 | 10.00M |
| 494 | VSTM | Verastem, Inc. | 460.46M | -2.96% | 1,060,942 | 49.59M |
| 495 | PRLD | Prelude Therapeutics Incorporated | 460.18M | -5.50% | 346,817 | 16.72M |
| 496 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.89M | -3.04% | 107,953 | - |
| 497 | SGMT | Sagimet Biosciences Inc. | 448.32M | -1.22% | 471,508 | - |
| 498 | DCTH | Delcath Systems, Inc. | 446.88M | -4.25% | 156,879 | 90.44M |
| 499 | ARTV | Artiva Biotherapeutics, Inc. | 446.77M | -2.28% | 240,276 | 251.00K |
| 500 | CCCC | C4 Therapeutics, Inc. | 445.59M | -6.06% | 1,247,707 | 34.86M |